National Institute of Health Resources for Stem Cell Research
Stem Cell Basics These pages present a basic overview of stem cells and their potential uses.

News, information and commentary on public policy and business issues involving California's new stem cell agency, the California Institute for Regenerative Medicine, created by Prop. 71. - (Read more)

The Illinois Regenerative Medicine Institute (IRMI) was established in July 2005 by Gov. Rod R. Blagojevich to provide state support for stem cell research, a rapidly growing scientific field that promises advances in understanding the causes of disease and the capacity to treat and cure.

IRMI is committed to applying this cutting-edge scientific knowledge to safeguard and improve the health of Illinois citizens.

The Center for Biologics Evaluation and Research (CBER) regulates human gene therapy products - products that introduce genetic material into the body to replace faulty or missing genetic material, thus treating or curing a disease or abnormal medical condition. CBER uses both the Public Health Service Act and the Federal Food Drug and Cosmetic Act as enabling statutes for oversight. FDA has not yet approved any human gene therapy product for sale. However, the amount of gene-related research and development occurring in the United States continues to grow at a fast rate and FDA is actively involved in overseeing this activity.

State of New Jersey, The Commission on Science and Technology 
New Jersey’s stem cell research initiative is a multi-faceted effort to create and build a vibrant stem cell research community that will develop innovative treatments for patients and generate economic opportunity and job growth in New Jersey. - (Read more)